Obesity is linked to a wide range of health conditions, including heart disease, diabetes, cancer, and stroke
View image online ( An uncapped GLP-1 injector on counter Ozempic, a once-weekly injectable medication used to help manage blood sugar levels for people living with Type 2 diabetes, may be one of the most talked-about medications in recent history
In recent years, there has been an increase in the morbidity, disability rate,and mortality due to obesity, making it great threat to peoples health and lives, and increasing public health care expenses
This mechanism, evident in pramlintide, involves amylin-based pathways
Following the SCALE clinical trial program, it received a second FDA approval in December 2014 as Saxenda for chronic weight management making it the first GLP-1 agonist approved for obesity treatment
Some patients experience persistent gastrointestinal side effects that may limit long-term tolerability